Correspondence

Sydney Morning Herald. May 13, pp2 and 30.

Mersky H. Multiple personality disorder and false memory syndrome. British Journal of Psychiatry 1993; 166:281–183–612.

Loftus EF. The reality of repressed memories. American Psychologist 1993; 48:518–537.

Piper AJ. Multiple personality disorder: a critical review. British Journal of Psychiatry 1991; 164:600–612.

Grounds D Stocky A Evans P Scott C McIntosh R Morrison E Derham H Farnbach P. Antidepressants and side effects. Australia and New Zealand Journal of Psychiatry 1995; 29:156–157.

Benkert H Hippius H. Psychiatrische Pharrnakotherapie. Berlin: Springer, 1980.

Feuerstein TJ Jackisch R. Why do some antidepressants promote suicide? Psychopharmacology 1986; 90:422.

Fava M Rosenbaum JF. Suicidality and fluoxetine: is there a relationship? Journal of Clinical Psychiatry 1991; 52:108–111.

Asberg M Nordstrom P. Biological correlates of suicidal behaviour. In: Moller H-J Schmidtke A Welz R , eds. Current issues in suicidology. New York:Springer, 1988:221–241.

Soloff PH George A Nathan RS Schulz PM Perel JM. Paradoxical effects of amitriptyline on borderline patients. American Journal of Psychiatry 1986; 143:1603–1605.

Parker G Austin M-P. A clinical perspective on SPECT. Australian and New Zealand Journal of Psychiatry 1995; 29: 38–47.

Volkow ND Tancredi L. Current and future applications of SPECT in clinical psychiatry. Journal of Clinical Psychiatry 1992; 53(11, Suppl): 26–28.

Salmon E Sadzot B Maquet P Differential diagnosis of Alzheimer's disease with PET. Journal of Nuclear Medicine 1994; 35:391–398.

Neumann MA Cohn R. Progressive sub-cortical gliosis: a rare form of presenile dementia. Brain 1967; 90: 405–418.

Holman BL Johnson KA Gerada B Carvalho PA Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium 99m-HMPAO. Journal of Nuclear Medicine 1992; 33: 181–185.

Spaminato U Habert MO Mas JL 99mTc HMPAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer's type. Journal of Neurology, Neurosurgery and Psychiatry 1991; 54: 787–792.

Eberl S Kanno I Fulton R General inter-study alignment for SPECT and PET studies. European Journal of Nuclear Medicine 1994; 21: S38.

Jarrit PH Kouris K. Instrumentation for brain SPET: guidelines for quantitation. In: Costa DC Morgan GF Lassen NA , eds. New trends in nuclear neurology and psychiatry. London: John Libbey 1993: 39–62.

Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. British Journal of Psychiatry 1994; 165:728–33.

Laruelle M Vanisberg MA Maloteaux JM. Regional and sub-cellular localization in human brain of (3H)paroxetine binding, a marker of serotonin uptake sites. Biological Psychiatry 1988; 24:299–309.

Fibiger HC Miller JJ. An anatomical and electrophysiological investigation of serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat. Neuroscience 1977; 2:975–987.

Lipinski JF Jr Mallya G Zimmerman P Pope HG Jr Fluoxetine-induced akathisia: clinical and theoretical implications. Journal of Clinical Psychiatry 1989; 50:339–342.

Otton SV Wu D Joffe RT Cheung SW Sellers EM. Inhibition by fluoxetine of cytochrome P450 2D6 activity. Journal of Clinical Pharmacology and Therapeutics 1993; 53:401–409.

Budman CL Bruun RD. Persistent dyskinesia in a patient receiving fluoxetine. American Journal of Psychiatry 1991; 148:1403.

RANZCP Committee on Psychotropic Drugs and Other Physical Treatments. Guidelines for Psychotropic Drugs in Psychiatric Practice 1994: 28–30.

Psychotropic Drug Guidelines Sub-Committee, Victorian Drug Usage Advisory Committee. Psychotropic guidelines. Victoria: Interprint, 1993: 108–109.

Tiller JWG. Re: tricyclic antidepressants in childhood. Bulletin of the Faculty of Child and Adolescent Psychiatry, 1994:67.

Viesselman JO Antidysthymic drugs (antidepressants and antimanics). In: Practitioner's guide to psychoactive drugs for children and adolescents. Werry JS Aman MG , eds. New York: Plenum, 1993: 246.

Baker S. Desipramine and sudden death in children. Pharmabulletin. Victoria: Health and Community Services 1994:67.

Riddle MA Sudden death in children receiving Norpramin (desipramine): a review of three reported cases and commentary. Journal of the American Academy of Child and Adolescent Psychiatry 1991; 30:104–108.

Riddle MA Another sudden death in a child treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry 1993; 32:792–797.

Walsh T Effects of desipramine on autonomic control of the heart. Journal of the American Academy of Child and Adolescent Psychiatry 1994; 33:191–197.

Werry JS. The safety of desipramine. Letter: Journal of the American Academy of Child and Adolescent Psychiatry 1994; 33:588–589.